End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,560 KRW | -2.28% | -7.33% | -19.19% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
EPO Medicine
46.6
%
| 3,796 | 58.4 % | 3,410 | 46.6 % | -10.15% |
Consignment Production (CMO)
21.8
%
| 1,049 | 16.1 % | 1,593 | 21.8 % | +51.86% |
Others
14.7
%
| 420 | 6.5 % | 1,072 | 14.7 % | +155.31% |
Technology Transfer (CDO)
13.2
%
| 547 | 8.4 % | 969 | 13.2 % | +77.30% |
Royalty
3.7
%
| 690 | 10.6 % | 271 | 3.7 % | -60.76% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
63.6
%
| 2,843 | 43.7 % | 4,654 | 63.6 % | +63.71% |
Overseas
36.4
%
| 3,658 | 56.3 % | 2,661 | 36.4 % | -27.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jae-Seung Yoon
CEO | Chief Executive Officer | 63 | 10-01-28 |
Jae-Hong Jang
DFI | Director of Finance/CFO | 58 | 10-11-30 |
Jung-Soo Park
CTO | Chief Tech/Sci/R&D Officer | 54 | 10-01-28 |
Tae-Ho Byun
COO | Chief Operating Officer | 65 | 10-01-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Jae-Seung Yoon
CEO | Chief Executive Officer | 63 | 10-01-28 |
58 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,414,683 | 6,137,836 ( 53.77 %) | 0 | 53.77 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-19.19% | 46.06M | |
+51.85% | 57.87B | |
+40.94% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- A222110 Stock
- Company PanGen Biotech Inc.